Background
As a result of the Trans-NIH A-T Research Working group, the NIH has developed
a Program Announcement for A-T to:
- encourage basic and translational studies,
- determine how the symptoms of A-T develop,
- stimulate the development of
resources to further A-T research,
- accelerate research into promising
therapeutic approaches for A-T and
- stimulate progress in A-T research
through encouraging and facilitating interdisciplinary interactions.
This
Program Announcement uses three different NIH grant mechanisms:
Partnership with the NIH
A partnership has been set up between the A-T Children’s Project and certain
NIH institutes participating in the Program Announcement for A-T. In this
partnership, applicants who submit grant proposals under the Program
Announcement, but who are unsuccessful in obtaining NIH funding, are
encouraged to authorize the distribution of their NIH review summary
statements to the A-T Children’s Project for funding consideration. In
addition to the summary statements, the A-T Children’s Project will also
require that the applicant submit a modified grant application based on our
grant proposal guidelines (http://www.atcp.org/Grant_guidelines.htm).
Investigators should note the following:
• The A-T Children's Project is currently focusing its funding efforts on
grant proposals that:
◊ explore the neurobiology of the ATM protein
◊ facilitate translational or clinical research for A-T
• The A-T Children’s Project funds one- and two-year projects up to a maximum
total direct cost of US$75,000 per year.
Questions
For questions concerning the NIH Program Announcement for A-T, please contact
Dan Tagle, PhD, Program Director, NINDS.
Phone: 301-496-5745
E-mail:
tagled@ninds.nih.gov
For questions regarding the A-T Children’s Project’s grant guidelines, please
contact our Science Coordinator Cynthia Rothblum-Oviatt, PhD.
Phone: 703-765-1223
E-mail: Cynthia@atcp.org
|